MSX2 overexpression inhibits gemcitabine-induced caspase-3 activity in pancreatic cancer cells

doi:10.3748/wjg.v11.i43.6867

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 43

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2402)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

232

HTML

2007

Figures (1-3)

150

Sum=2389

Nov 21, 2005 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Nov 21, 2005; 11(43): 6867-6870
Published online Nov 21, 2005. doi: 10.3748/wjg.v11.i43.6867

Full Size Figure Download Figure

Figure 1 A: Western blotting analysis of V5-tagged MSX2 expression in Px14 cells; B: detection of cell proliferation of P-3EV and Px14 by BrdU incorporation assay. No significant difference was observed in these two cell lines, but slight increase of proliferation ratio was observed in Px14 cells (unpaired t-test, n = 3).

Citation: Hamada S, Satoh K, Kimura K, Kanno A, Masamune A, Shimosegawa T. MSX2 overexpression inhibits gemcitabine-induced caspase-3 activity in pancreatic cancer cells. World J Gastroenterol 2005; 11(43): 6867-6870
URL: https://www.wjgnet.com/1007-9327/full/v11/i43/6867.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i43.6867